Jeffrey Alan McKinney

Title: The Innovations of Jeffrey Alan McKinney

Introduction

Jeffrey Alan McKinney is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds related to addiction and anxiety disorders. With a total of eight patents to his name, McKinney's work reflects a commitment to advancing medical science.

Latest Patents

Among his latest patents, McKinney has developed Ibogaine-related compounds and corresponding methods. This invention focuses on Ibogaine derivatives, specifically deutero- and fluoro-derivatives, which are aimed at treating addiction disorders. The methods he proposes involve the administration of these compounds to address not only addiction but also anxiety-related disorders and impulse control disorders. Another significant patent involves Pyridazino quinoline compounds, which includes pharmaceutical compositions and methods for utilizing these compounds effectively.

Career Highlights

Throughout his career, McKinney has worked with various companies, including Zeneca Limited. His experience in the pharmaceutical industry has allowed him to contribute to innovative solutions that address critical health issues. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

McKinney has collaborated with notable individuals such as Timothy W Davenport and Thomas Michael Bare. These partnerships have likely enhanced the scope and impact of his inventions, fostering a collaborative environment for innovation.

Conclusion

Jeffrey Alan McKinney's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the development of treatments for addiction and anxiety disorders, showcasing the importance of innovation in medicine.